David Hubbard, M.D.

David Hubbard, M.D., founder

David R Hubbard, MD, Founder

CURRENT POSITIONS

CHAIRMAN, Hubbard Foundation for fMRI Research, a charitable foundation supporting research and education in applied psychophysiology, San Diego, CA.

GENERAL MANAGER, Applied fMRI Institute, LLC, an applied functional MRI research institute, San Diego, CA.

CHIEF MEDICAL OFFICER AND MANAGING MEMBER, MyoLink, LLC, a pharmaceutical development company, San Diego, CA.

MANAGING MEMBER, Film Devil Productions, LLC, a movie production company, Santa Barbara, CA.

CONSULTANT IN PAIN MANAGEMENT, to the healthcare and pharmaceutical industries.

ASSOCIATE CLINICAL PROFESSOR OF NEUROLOGY, retired, University of California, San Diego

ADJUNCT PROFESSOR OF PSYCHOLOGY, San Diego State University

ADJUNCT PROFESSOR OF PSYCHOLOGY, California School of Professional Psychology, Alliant International University, San Diego

MEDICAL EXPERT, Pain Neurology, Medical Board of California

EDITORIAL BOARD, Journal of Applied Psychophysiology and Biofeedback

EDITORIAL BOARD, Practical Pain Management

CURRENT RESEARCH

Real-time functional MRI methods

Collaboration with No Lie MRI, Inc., San Diego, CA on research development of fMRI in lie detection and truth verification

EDUCATION

STUDENT, Cognitive Science, University of California, San Diego, 2003-present.

CHIEF RESIDENT, NEUROLOGY, Albert Einstein College of Medicine, Bronx, NY, 1980-1981.

RESIDENT, NEUROLOGY, Albert Einstein College of Medicine, Bronx, NY, 1978-1980.

INTERN, MEDICINE, Waterbury Hospital – Yale University, 1977-1978.

M.D., University of Connecticut School of Medicine, 1977.

M.A. COUNSELING PSYCHOLOGY, Stanford University, 1971.

B.A. PHILOSOPHY, Yale University, 1970.

Phillips Exeter Academy, 1963-1966

BOARD CERTIFICATION

DIPLOMATE IN NEUROLOGY, American Board of Neurology and Psychiatry, 1984.

MEDICAL LICENSES

California G50317
New York 141424

ASSOCIATIONS

American Academy of Neurology
Association for Applied Psychophysiology and Biofeedback
International Society for Neurofeedback and Research
American Pain Society
Academy of Pain Medicine

HONORS

“Beyond the Call of Duty” Award, Scripps Memorial Hospital, La Jolla, California, March 1990.

Scholastic Excellence Award, University of Connecticut School of Medicine, 1977.

spacer

PUBLICATIONS

Oliveira A, Gevirtz G, Hubbard D. A psycho-educational video used in the emergency department provides effective treatment for whiplash injuries. Spine, 31,15,1652-1657, 2006.

Landis D, Hubbard D, Cua P, Walker D. Disease management of chronic pain improves employee productivity and lowers healthcare costs. Health & Productivity Management, 2,2, May 2003.

Hubbard D. Guidelines for Musculoskeletal and Chronic Pain, Breaking Down the Barriers of Pain. Practical Pain Management, Vol. 1-5, Jan-Sept, 2001.

Hubbard D. Persistent muscular pain: Approaches to relieving trigger points. J. Musculoskeletal Medicine 15, No. 5, 16-26, May, 1998.

Hubbard D. Chronic and recurrent muscle pain: pathophysiology, treatment and review of pharmacologic studies. J. Musculoskeletal Pain 4,1/2,123-143, 1996.

Gevirtz R, Hubbard D, Harpin R. Psychophysiologic treatment of chronic lower back pain. Professional Psychology: Research and Practice 27,6,561-566, 1996.

Hubbard D. Getting Tension. Biofeedback Newsletter, 1, 14-16, 1996.

Lewis C, Gevirtz R, Hubbard D., Berkoff G. Needle trigger point and surface frontal EMG measurements of psychophysicological responses in tension-type headache patients. Biofeedback & Self-Regulation 19, 3, 274-275, 1994.

McNulty W, Gevirtz R, Berkoff G, Hubbard D. Needle electromyographic evaluation of trigger point response to a psychological stressor, Psychophysiology, 31, 313-316, 1994.

Hubbard D, Berkoff B. Myofascial trigger points studied by needle EMG. Spine, 18, 13, 1803-1807, 1993.

Cady R, et al. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 265(21):2831-2835, 1985.

Hubbard D. Adrenocortical responsiveness: lack of correlation to life events, Type A trait or locus of control, Psychosom Med, 45, 1, 80, 1983.

Reinitz E, Hubbard D, Grayzel A. Central nervous system systemic lupus erythematosus vs. CNS infection; low CSF glucose and pleocytosis in a patient with a prolonged course, Arth Rheum, I25, 5, 583, 1982.

Hannum J, Thoresen C, Hubbard D. A behavioral study of self-esteem with elementary teachers. In Mahoney M, Thoresen C. (eds) Self-Control: Power to the Person, Monterey, Brooks/Cole, 1974.

PATENTS

Hubbard, David R: Pharmaceutical formulations of sympathetic antagonist for the treatment of chronic muscle pain. Filed February 17, 2006.

Hubbard, David R.: Multi-electrode and needle injection device for the diagnosis and treatment of muscle injury and pain, U.S. Patent No. 6,678,550 B2, Jan 13, 2004.

Hubbard, David R.: Multi-electrode and needle injection device for the diagnosis and treatment of muscle injury and pain, U.S. Patent No. 6,356,783 B1, Mar 12, 2002.

Hubbard, David R.: Multi-electrode and needle injection device for the diagnosis and treatment of muscle injury and pain, U.S. Patent No. 10/017,072, Dec 7, 2001.

Hubbard, David R. and Johnson, Paul. Methods and equipment for treating or preventing muscle pain or injury. Australian Patent No. 731029, July 5, 2001.

Hubbard, David R.: Methods and equipment for treating muscle injury and pain, U.S. Patent No. 6,155,994, Dec. 5, 2000.

Hubbard, David R: Use of sympathetic antagonists for treatment of chronic muscle pain, U.S. Patent No. 6,009,875, Jan. 4, 2000.

Hubbard, David R.: Multi-electrode and needle injection device for the diagnosis and treatment of muscle injury and pain, Int’l Patent No. WO9822021, May 28, 1998.

Hubbard, David R.: Use of sympathetic blockade for treatment of chronic muscle pain, U.S. Patent No. 5,513,661, May 7, 1996.

EXPERIENCE

Medical Director, Musculoskeletal and Chronic Pain, Matria Healthcare, Inc., Atlanta, Georgia, 2006.

Medical Director, Musculoskeletal and Chronic Pain, CorSolutions Medical, Inc. Rosemont, Illinois, 2001-2006.

Consultant to HealthNet, Woodlawn, CA: “Guidelines To Appropriate Chronic Pain Management,” 2004.

Consultant to Schering-Berlex: FDA Phase 2 trial, “Phenoxybenzamine intramuscular injection for chronic myofascial pain. MyoLink and Schering-Berlex.

Medical Director, MyoPoint Pain Management Medical Group, San Diego, CA, 1997-2001.

Medical Director, Sharp Pain Rehabilitation Services, Sharp HealthCare, San Diego, CA, 1992-1998.

Associate Clinical Professor, Pain Neurology Residents Clinic, University of California, San Diego, 1983-2000.

Principal investigator, Phase III Clinical trials of sumatriptan, 1989-1993.

Co-Founder and Chairman of the Board, Country Montessori School. Poway, CA. 1987-1994.

FDA Phase III Clinical Trial of nimodipine in Migraine, 1985-1986.

Instructor of Neurology, Departments of Psychiatry and Neurology, Cornell Medical Center, New York Hospital, Westchester Division, 1982-1983.

Instructor of Neurology, Department of Neurology, Albert Einstein College of Medicine, Montefiore Hospital, 1981-1982.

Attending and Supervisor of Biofeedback, Montefiore Headache and Pain Unit, 1978-1983.

Director, Clinical Evoked Potential Laboratory, Department of Neurology, Montefiore Medical Center, Albert Einstein College of Medicine, 1979-1982.

Neurology Director, Center for Neuropsychological Services, Montefiore Medical Center, 1981-1982.

Extern, Aphasia Research Unit, D. Frank Benson, M.D., Director, Boston VA Hospital, Boston University School of Medicine, 1976.

Extern, Maida Vale Hospital and Queens Square Hospital, London, 1974.

Extern, Psychophysiology Clinic, Charles Stroebel, Ph.D., M.D., Director, Institute of Living, Hartford, Connecticut, 1975.

Neurochemistry Laboratory, Jack Barchas, M.D., Director, Stanford University School of Medicine, 1974.Stanford Center for Research and Development in Teaching, 1971-1973.

ALSO

Born Feb. 25, 1948 Hartford, CT. Married to Arlene Pellar Hubbard, OTR, MA Counseling Psychology, since 1980; children Devin P Hubbard born 1982, and Alexandra W Hubbard born 1984, both in college. Home in Poway, CA since 1987.